Shares of Eden Research plc (LON:EDEN – Get Free Report) shot up 18.4% during trading on Tuesday. The company traded as high as GBX 2.90 and last traded at GBX 2.90. Approximately 3,891,780 shares traded hands during mid-day trading, an increase of 598% from the average session volume of 557,270 shares. The stock had previously closed at GBX 2.45.
Eden Research Trading Up 18.4%
The business’s 50-day moving average price is GBX 2.27 and its 200 day moving average price is GBX 3.05. The company has a market cap of £23.30 million, a P/E ratio of -6.54 and a beta of 1.61. The company has a debt-to-equity ratio of 5.41, a quick ratio of 2.42 and a current ratio of 1.95.
Eden Research (LON:EDEN – Get Free Report) last issued its earnings results on Wednesday, August 26th. The company reported GBX (0.36) earnings per share (EPS) for the quarter. Eden Research had a negative net margin of 50.43% and a negative return on equity of 16.16%. As a group, analysts expect that Eden Research plc will post -66.00 earnings per share for the current year.
About Eden Research
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.
Further Reading
- Five stocks we like better than Eden Research
- Charging Ahead: Solid Power’s Pilot Line Leaves the Lab
- Off-Price, High-Yield: Why Ross Stores Is Defying the Retail Slump
- Whirlpool’s Stock Collapse Raises a Bigger Question About Its Recovery Potential
- Analysts Turn Bullish on Meta Platforms Despite Post-Earnings Fall
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.
